SCHEMBL8641646

SCHEMBL8641646

O=C(NC1CN(Cc2ccccc2)CC[N]C1=O)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 2/20 0.46
▸ CTSB P07858 2/20 0.46
▸ CTSK P43235 1/20 0.46
▸ NAAA Q02083 1/20 0.45
▸ TGM2 P21980 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ PREP P48147 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ BCHE P06276 2/20 0.42
▸ MAOB P27338 2/20 0.42
▸ ACHE P22303 1/20 0.42
▸ CASP3 P42574 1/20 0.42
▸ CPB1 P15086 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8641654 1.00 CTSL (0.46) CTSLCTSBCTSKNAAATGM2
SCHEMBL13547350 0.81 SMN1; SMN2 (0.47) CTSLCTSBCTSKNAAATGM2
SCHEMBL5692127 0.76 CTSL (0.67) CTSLCTSBCTSKTGM2ALDH1A1
SCHEMBL949589 0.75 CTSK (0.43) CTSLCTSBCTSKALDH1A1TSHR
SCHEMBL949590 0.75 CTSK (0.43) CTSLCTSBCTSKALDH1A1TSHR
SCHEMBL8764157 0.74 KAT2B (0.46) CTSLCTSBCTSKALDH1A1PREP
SCHEMBL6199732 0.74 CASP3 (0.60) CTSLCTSBCTSKALDH1A1GAA
SCHEMBL5122686 0.73 TGM2 (0.67) CTSLCTSBCTSKTGM2ALDH1A1
SCHEMBL11031828 0.73 TSHR (0.52) CTSLCTSBCTSKNAAAALDH1A1
SCHEMBL11031824 0.73 TSHR (0.52) CTSLCTSBCTSKNAAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5847135-A Inhibitors of interleukin-1β converting enzyme VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-12-08 — — US disclosed
US-5716929-A THERAPY FOR INFLAMMATION, AUTOIMMUNE DISEASES VERTEX PHARMACEUTICALS, INC. (US) 1998-02-10 — — US disclosed
Send feedback